Monitoring dendritic cell and cytokine biomarkers during remission prior to relapse in patients with FLT3-ITD acute myeloid leukemia

Relapse occurs frequently after treatment of acute myeloid leukemia (AML) patients with the FMS-like tyrosine kinase 3-internal tandem duplication (ITD) mutation. The availability of immunologic biomarkers to predict patients at high risk could allow clinicians to accelerate alternative treatments s...

Descripción completa

Detalles Bibliográficos
Autores principales: Rickmann, Mareike, Macke, Laura, Sundarasetty, Bala Sai, Stamer, Kathrin, Figueiredo, Constanca, Blasczyk, Rainer, Heuser, Michael, Krauter, Juergen, Ganser, Arnold, Stripecke, Renata
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2013
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3701796/
https://www.ncbi.nlm.nih.gov/pubmed/23616009
http://dx.doi.org/10.1007/s00277-013-1744-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3701796/
https://www.ncbi.nlm.nih.gov/pubmed/23616009
http://dx.doi.org/10.1007/s00277-013-1744-y

Ejemplares similares